07208582 is referenced by 26 patents and cites 118 patents.

Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.

Title
Vascular endothelial growth factor 2
Application Number
10/120414
Publication Number
7208582 (B2)
Application Date
April 12, 2002
Publication Date
April 24, 2007
Inventor
Ruth E Wager
Rockville
MD, US
Steven M Ruben
Olney
MD, US
Vivian R Albert
Rockville
MD, US
Craig A Rosen
Laytonsville
MD, US
Agent
Sterne Kessler Goldstein & Fox P L L C
Assignee
Human Genome Sciences
MD, US
IPC
C07K 21/08
C07K 16/22
View Original Source